Member Info for RayPointer

Https://www.standard.co.uk/hp/front/you-wait-ages-for-a-london-bus-then-20-come-along-a3245631.html

I thought it was a shame that Scancell terminated the SCIB1 + Keytruda cohort.

Small numbers but it was showing promise

Thanks Seis

As always you are a reliable source of information

Does anybody know the price of cobalt that is required to make it worthwhile to resurrect the idea of a cobalt circuit?

Cleaner

Remember that Scancell have already trialled SCIB1 as a monotherapy in the adjuvant setting with great results (albeit with small numbers).

This will be of great interest to potential investors in the next stage for iSCIB1+.

Thanks Chelsea

So it looks like the SCIB1/iSCIB1+ season will continue perhaps up until a possible deal is announced.

Chester

I think of more interest is what Scancell will be promoting at conferences from now on.

Is the SCIB1/iSCIB1+ season now over and will Scancell be concentrating on other elements of the pipeline?

Modi1 and SC134 spring to mind.

Just saying that what Val are doing is brilliant is, in itself, not much use to potential investors.

What would be really useful is a comparison of what Val are doing to what other companies are doing in the same area.

Is it really cutting edge and is Val ahead of the game?

Vulpes is very much a Diggle family firm

https://vulpesinvest.com/our-people/

Yeah, I saw that too Rats and couldn't help laughing.

I've never had him down as a pole vaulter

This is a statement from the little green men party

LOL

"Even more so, when Mark admits it was money earmarked to clear his mortgage. Few other investors would show that degree of commitment."

I would guess that, if there is a Mrs Eccleston, she is not too pleased 🤣

I should have listened more carefully to the Q&A session. 🤣

Hi Bibio

"My question is - was there any indication given as to why the Renal Cell cohort was pushed out ?"

I don't recall them giving a reason. I would guess that the unpredictable recruitment rate is the reason. Were the Modi1 trial within the CVLP, the story would no doubt be very different.

It would be nice if we got a stage payment from Genmab in the near future for the first of the 2 mAbs:

1) It would lengthen the cash runway by 2 or 3 months

2) It reminds people that we have 2 deals with Genmab

3) It shows Genmab are still liking what they see

Possibly a little bottle of vodka

Ruck

Elliot Waves are a rare event in East Lancashire, last seen in 1960.

Ruck

You never know, Scancell might be just waiting for the next Elliot Wave to arrive.

Surfboards at the ready

Thanks Marcus

That doesn't sound as good as the SCIB1 monotherapy results for resected stage III/IV melanoma.